X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (138) 138
hematology (109) 109
index medicus (96) 96
female (68) 68
male (68) 68
aged (66) 66
myelodysplastic syndromes (64) 64
middle aged (63) 63
aged, 80 and over (51) 51
medicin och hälsovetenskap (49) 49
myelodysplastic syndromes - genetics (48) 48
medical and health sciences (45) 45
oncology (44) 44
myelodysplastic syndromes - drug therapy (41) 41
adult (38) 38
myelodysplastic syndrome (35) 35
acute myeloid-leukemia (33) 33
klinisk medicin (33) 33
prognosis (33) 33
myelodysplastic syndromes - pathology (30) 30
treatment outcome (30) 30
clinical medicine (29) 29
mutation (28) 28
cancer (27) 27
hematologi (26) 26
anemia (23) 23
myelodysplastic syndromes - diagnosis (23) 23
myelodysplastic syndromes - therapy (23) 23
survival (23) 23
classification (21) 21
colony-stimulating factor (21) 21
leukemia (20) 20
myelodysplastic syndromes - mortality (20) 20
scoring system (20) 20
chromosome deletion (19) 19
erythropoietin - therapeutic use (17) 17
mds (17) 17
medicine (17) 17
apoptosis (16) 16
erythropoietin (16) 16
abridged index medicus (15) 15
azacitidine (15) 15
azacitidine - therapeutic use (14) 14
disease progression (14) 14
expression (14) 14
gene expression profiling (14) 14
hematology, oncology and palliative medicine (14) 14
hemic and lymphatic diseases (14) 14
medicin (14) 14
prognostic scoring system (14) 14
risk factors (14) 14
myelodysplasia (13) 13
thalidomide - analogs & derivatives (13) 13
cells (12) 12
chromosomes, human, pair 5 (12) 12
chromosomes, human, pair 5 - genetics (12) 12
dna methylation (12) 12
myelodysplastic syndromes - complications (12) 12
risk (12) 12
antimetabolites, antineoplastic - therapeutic use (11) 11
antineoplastic agents - therapeutic use (11) 11
cell biology (11) 11
g-csf (11) 11
genetic aspects (11) 11
leukemia, myeloid, acute - genetics (11) 11
mutations (11) 11
research (11) 11
thalidomide - therapeutic use (11) 11
article (10) 10
blood transfusion (10) 10
bone marrow - pathology (10) 10
cohort studies (10) 10
diagnosis (10) 10
flow cytometry (10) 10
gene (10) 10
granulocyte colony-stimulating factor - therapeutic use (10) 10
hematopoietic stem cells - pathology (10) 10
identification (10) 10
impact (10) 10
myelodysplastic syndromes - classification (10) 10
remission induction (10) 10
survival analysis (10) 10
world-health-organization (10) 10
acute myeloid leukemia (9) 9
bone marrow (9) 9
bone-marrow (9) 9
care and treatment (9) 9
case-control studies (9) 9
chemotherapy (9) 9
gene expression (9) 9
lenalidomide (9) 9
medical research (9) 9
quality-of-life (9) 9
cells, cultured (8) 8
down-regulation (8) 8
follow-up studies (8) 8
international working group (8) 8
myelodysplastic syndromes - blood (8) 8
survival rate (8) 8
therapy (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Haematology, ISSN 0007-1048, 03/2003, Volume 120, Issue 6, pp. 1037 - 1046
Journal Article
Blood, ISSN 0006-4971, 07/2015, Volume 126, Issue 2, pp. 233 - 241
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 7/2007, Volume 104, Issue 27, pp. 11406 - 11411
Myelodysplastic syndromes (MDSs) are a group of hematopoietic stem cell disorders characterized by ineffective hematopoiesis and peripheral blood cytopenias.... 
Cell growth | Erythroblasts | Myeloid leukemia | Gene expression profiling | Leukemia | Cell lines | Cultured cells | Gene expression | Progenitor cells | Myelodysplastic syndromes | Erythropoiesis | Microarray | Osteonectin | osteonectin | MULTIDISCIPLINARY SCIENCES | MULTIPLE-MYELOMA CELLS | POTENT INHIBITORS | microarray | ACTIVIN-A | MATRICELLULAR PROTEIN | myelodysplastic syndromes | EXTRACELLULAR-MATRIX | erythropoiesis | TNF-ALPHA | THALIDOMIDE ANALOGS | PROGNOSTIC-SIGNIFICANCE | gene expression profiling | 5T4 ONCOFETAL ANTIGEN | Chromosome Deletion | Humans | Chromosome Mapping | Thalidomide - pharmacology | Osteonectin - biosynthesis | Thalidomide - analogs & derivatives | Osteonectin - genetics | Antineoplastic Agents - pharmacology | Clone Cells | Myelodysplastic Syndromes - genetics | Gene Expression Regulation, Neoplastic - drug effects | Tumor Cells, Cultured | Erythroblasts - drug effects | Myelodysplastic Syndromes - pathology | Growth Inhibitors - pharmacology | Myelodysplastic Syndromes - drug therapy | Chromosomes, Human, Pair 5 - genetics | Erythroblasts - pathology | Genetic aspects | Chromosome deletion | Research | Genetic regulation | Biological Sciences | Basic Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | Cell and Molecular Biology | Cell- och molekylärbiologi
Journal Article
Haematologica, ISSN 0390-6078, 07/2011, Volume 96, Issue 7, pp. 963 - 971
Background Patients with chromosome 5 abnormalities and high-risk myelodysplastic syndromes or acute myeloid leukemia have a poor outcome. We hypothesized that... 
Lenalidomide | Acute myeloid leukemia | Myelodysplastic syndrome | P53 mutation | DIAGNOSIS | RESPONSE CRITERIA | EFFICACY | THERAPY-RELATED MYELODYSPLASIA | INTERNATIONAL WORKING GROUP | P53 | DELETION | acute myeloid leukemia | lenalidomide | SCORING SYSTEM | KARYOTYPE | myelodysplastic syndrome | HEMATOLOGY | WT1 Proteins - metabolism | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Oncogene Protein p21(ras) - metabolism | Tumor Suppressor Protein p53 - genetics | Thalidomide - analogs & derivatives | Antineoplastic Agents - adverse effects | Base Sequence | Aged, 80 and over | Biomarkers, Tumor - metabolism | Leukemia, Myeloid, Acute - drug therapy | Female | WT1 Proteins - genetics | Myelodysplastic Syndromes - drug therapy | Chromosomes, Human, Pair 5 - genetics | Thalidomide - adverse effects | Tumor Suppressor Protein p53 - metabolism | Treatment Outcome | Gene Expression Regulation, Leukemic | Thalidomide - administration & dosage | Mutation - genetics | Leukemia, Myeloid, Acute - mortality | Chromosome Aberrations | Myelodysplastic Syndromes - mortality | Aged | Biomarkers, Tumor - genetics | Myelodysplastic Syndromes - genetics | Leukemia, Myeloid, Acute - genetics | Oncogene Protein p21(ras) - genetics | Original | Medical and Health Sciences | Hematology | Internal medicine | Medicin och hälsovetenskap | Klinisk medicin | MEDICINE | Dermatology and venerology,clinical genetics, internal medicine | Clinical Medicine | Haematology | Hematologi | MEDICIN | Invärtesmedicin | Dermatologi och venerologi, klinisk genetik, invärtesmedicin
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 02/2018, Volume 180, Issue 4, pp. 526 - 533
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2018, Volume 181, Issue 5, pp. 614 - 627
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2009, Volume 10, Issue 3, pp. 223 - 232
Journal Article
Journal Article